|Articles|December 1, 2002

Supplements and Featured Publications

  • Health-Related Consequences of and Treatment Strategies for Overactive Bladder
  • Volume 8
  • Issue 19 Suppl

Participating Faculty

Download PDF: Participating Faculty

Articles in this issue

about 23 years ago

Health-Related Consequences of and Treatment Strategies for Overactive Bladder

about 23 years ago

Health-Related Consequences of Overactive Bladder

about 23 years ago

Health-Related Quality of Life Patients Receiving Extended-Release Tolterodine for Overactive Bladder

about 23 years ago

Long-term Health-Related Quality of Life of Patients Receiving Extended-Release Tolterodine for Overactive Bladder

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text